791 related articles for article (PubMed ID: 16955685)
1. Serogroup B meningococcal vaccines.
Zimmer SM; Stephens DS
Curr Opin Investig Drugs; 2006 Aug; 7(8):733-9. PubMed ID: 16955685
[TBL] [Abstract][Full Text] [Related]
2. Meningococcal disease: a review on available vaccines and vaccines in development.
Bröker M; Fantoni S
Minerva Med; 2007 Oct; 98(5):575-89. PubMed ID: 18043565
[TBL] [Abstract][Full Text] [Related]
3. Meningococcal vaccines.
Danzig L
Pediatr Infect Dis J; 2004 Dec; 23(12 Suppl):S285-92. PubMed ID: 15597071
[TBL] [Abstract][Full Text] [Related]
4. Meningococcal vaccines.
Collins CL; Pollard AJ
Curr Opin Investig Drugs; 2002 Jul; 3(7):975-9. PubMed ID: 12186274
[TBL] [Abstract][Full Text] [Related]
5. The epidemiology of meningococcal disease and the impact of vaccines.
Khatami A; Pollard AJ
Expert Rev Vaccines; 2010 Mar; 9(3):285-98. PubMed ID: 20218857
[TBL] [Abstract][Full Text] [Related]
6. Meningococcal serogroup B infections: a search for a broadly protective vaccine.
Vermont CL; van den Dobbelsteen GP
Expert Rev Vaccines; 2003 Oct; 2(5):673-81. PubMed ID: 14711328
[TBL] [Abstract][Full Text] [Related]
7. Quadrivalent meningococcal conjugate vaccines.
Pace D; Pollard AJ; Messonier NE
Vaccine; 2009 Jun; 27 Suppl 2():B30-41. PubMed ID: 19477560
[TBL] [Abstract][Full Text] [Related]
8. Challenges and progress in the development of a serogroup B meningococcal vaccine.
Lewis S; Sadarangani M; Hoe JC; Pollard AJ
Expert Rev Vaccines; 2009 Jun; 8(6):729-45. PubMed ID: 19485754
[TBL] [Abstract][Full Text] [Related]
9. A review of vaccine research and development: meningococcal disease.
Girard MP; Preziosi MP; Aguado MT; Kieny MP
Vaccine; 2006 May; 24(22):4692-700. PubMed ID: 16621189
[TBL] [Abstract][Full Text] [Related]
10. Development of new vaccines against meningococcal disease.
Bröker M
Arzneimittelforschung; 2003; 53(12):805-13. PubMed ID: 14732960
[TBL] [Abstract][Full Text] [Related]
11. Meningococcal vaccine against serogroups A, C, Y and W-135: new preparation. Encouraging immunogenicity studies.
Prescrire Int; 2002 Apr; 11(58):35-8. PubMed ID: 11987309
[TBL] [Abstract][Full Text] [Related]
12. [Anti-meningococcal vaccines].
Taha MK; Alonso JM
Rev Prat; 2008 Dec; 58(19):2099-101. PubMed ID: 19213536
[TBL] [Abstract][Full Text] [Related]
13. Meningococcal vaccine evolution.
Bona G; Guidi C
J Prev Med Hyg; 2012 Sep; 53(3):131-5. PubMed ID: 23362617
[TBL] [Abstract][Full Text] [Related]
14. Prevention of bacterial meningitis: an overview of Cochrane systematic reviews.
Prasad K; Karlupia N
Respir Med; 2007 Oct; 101(10):2037-43. PubMed ID: 17706408
[TBL] [Abstract][Full Text] [Related]
15. Properties and clinical performance of vaccines containing outer membrane vesicles from Neisseria meningitidis.
Holst J; Martin D; Arnold R; Huergo CC; Oster P; O'Hallahan J; Rosenqvist E
Vaccine; 2009 Jun; 27 Suppl 2():B3-12. PubMed ID: 19481313
[TBL] [Abstract][Full Text] [Related]
16. Recent developments in vaccines to prevent meningococcal serogroup B infections.
Vermont CL; van den Dobbelsteen GP; de Groot R
Curr Opin Mol Ther; 2003 Feb; 5(1):33-8. PubMed ID: 12669468
[TBL] [Abstract][Full Text] [Related]
17. Meningococcal disease: the advances and challenges of meningococcal disease prevention.
Yogev R; Tan T
Hum Vaccin; 2011 Aug; 7(8):828-37. PubMed ID: 21832882
[TBL] [Abstract][Full Text] [Related]
18. Vaccination against meningococcal disease in Europe: review and recommendations for the use of conjugate vaccines.
Trotter CL; Ramsay ME
FEMS Microbiol Rev; 2007 Jan; 31(1):101-7. PubMed ID: 17168998
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of serogroup A meningococcal vaccines in Africa: a demonstration project.
Soriano-Gabarró M; Rosenstein N; LaForce FM
J Health Popul Nutr; 2004 Sep; 22(3):275-85. PubMed ID: 15609780
[TBL] [Abstract][Full Text] [Related]
20. Challenges for development of meningococcal vaccines in infants and children.
Deasy A; Read RC
Expert Rev Vaccines; 2011 Mar; 10(3):335-43. PubMed ID: 21434801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
